Post by iOMEDICO

+++ 𝗣𝗘𝗥𝗙𝗢𝗥𝗠 𝘀𝘁𝘂𝗱𝘆 𝗱𝗮𝘁𝗮 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗲𝗱 𝗮𝘁 𝗔𝗦𝗖𝗢 𝟮𝟬𝟮𝟲 𝗶𝗻 𝗖𝗵𝗶𝗰𝗮𝗴𝗼 +++ We are proud to see PERFORM study data presented at #ASCO2026 in Chicago, USA, by Prof. Rupert Bartsch. The poster highlights real world findings in HR+/HER2- advanced breast cancer. The data show less favorable outcomes in patients with a treatment-free interval of 12 months or less and generally maintained quality of life during first-line treatment. We value the opportunity to contribute real world evidence from clinical practice to the international oncology community. Thank you to Prof. Bartsch for presenting this data at ASCO 2026. #ASCO2026 #BreastCancer #AdvancedBreastCancer #Oncology #RealWorldData #RealWorldEvidence #ClinicalResearch